Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma

Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma

This case report presents a 57-year-old male with hepatocellular carcinoma who developed Type 1 Diabetes Mellitus (T1DM) and diabetic ketoacidosis (DKA) following treatment with Envafolimab, a PD-L1 immune checkpoint inhibitor. The patient experienced a rapid onset of hyperglycemia and DKA after sev...

Full description

Saved in:
Bibliographic Details
Main Authors: Youjia Li, Kai Qu, Xiuli Li, Xin Yang, Kanghuai Zhang, Jiao Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
PD-L1
envafolimab
type 1 diabetes mellitus
diabetic ketoacidosis
immune checkpoint inhibitor
hepatocellular carcinoma
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1505195/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items